Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for…

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – ®(mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients with neurofibromatosis type 1 (NF1) aged 2 years and above. EZMEKLY is the first and only therapy approved in the European Union (EU) for both adults and children with NF1-PN...

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR…

To explore the valuable insights in the Preservative Free Eye Drops Market report, you can easily download a sample PDF of the report – https://www.theinsightpartners.com/sample/TIPRE00038962 To explore the valuable insights in the Preservative Free Eye Drops Market report, you can easily download a sample PDF of the report –https://www.theinsightpartners.com/sample/TIPRE00038962 The preservative-free eye drops market is segmented on the basis of type, application, and distribution...

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR |…

Browse in-depth TOC on 'Sleep Apnea Devices Market' Browse in-depth TOC on 'Sleep Apnea Devices Market' 739 - Tables 51 - Figures 497 - Pages By product type,the sleep apnea devices market is categorized into two main product types: therapeutic devices and diagnostic devices. In 2024, the therapeutic devices segment emerged as the dominant player in the market, capturing the largest share. This growth can be attributed to continuous advancements in technology focused on...

Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR…

To explore the valuable insights in the Technetium-99m Market report, you can easily download a sample PDF of the report- https://www.theinsightpartners.com/sample/TIPRE00029981 Some of the reasons behind Tc-99m's medical popularity are its ideal imaging properties, such as a short half-life of about six hours, suitable gamma energy, as well as providing a low radiation dose, giving it the capability to image organs such as the brain, heart, bones, lungs, kidneys, thyroid,...

Healthcare Dispensing Systems Market worth $6.27 billion by 2030 with 6.3% CAGR…

Browse in-depth TOC on "Healthcare Dispensing Systems Market" Browse in-depth TOC on "Healthcare Dispensing Systems Market" 400 - Tables 50 - Figures 400 - Pages By type,the market is divided into automatic dispensing systems, semi-automated dispensing systems, stand-alone/manual dispensing instruments, and OEM/dispensing components. Automatic dispensing systems accounted for the largest share of the healthcare dispensing systems market in 2024. Their dominance is...

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief…

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development Atif Abbas, MD joins as CMO, bringing over 25 years’ experience in oncology drug development and clinical and regulatory strategyCarolyn Edwards, PhD appointed VP, R&D, with over 15 years’ expertise in drug development and strategic partneringEdinburgh, UK, 18 July 2025 - Trogenix Ltd (“Trogenix”), a...

The World Federation of Neurology to Host Global Webinar Uniting UN-ECOSOC, WHO…

"When one in three is affected by a brain disorder—and nearly 90% of this burden occurs in low- and middle-income countries, this campaign becomes not just important, but essential," said Professor Tissa Wijeratne, Co-Chair of World Brain Day. "It reflects a global commitment to protecting brain health across one's entire lifespan, from preconception through aging adulthood, ensuring that no one is left behind." "When one in three is affected by a brain disorder—and…

Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint MedicinesParis, July 18, 2025. Sanofi today announces the completion of itsacquisition of Blueprint Medicines Corporation(Blueprint), adding to its portfolio a commercialized medicine, a promising pipeline, and the expertise of a company specializing in systemic mastocytosis (SM), a rare immunological disease, and other KIT-driven diseases.In addition, the acquisition of Blueprint brings Sanofi an established presence among allergists,...

SERM Market Shows Promising Growth Trajectory During the Study Period…

Key Takeaways from the SERM Market Report Key Takeaways from the SERM Market Report Discover which indication is expected to grab the major SERM market share @SERM Market Report SERM Market Dynamics The SERM market is witnessing dynamic growth, driven by anincreasing prevalence of hormone-related disorderssuch as breast cancer, osteoporosis, and infertility. SERMs function by selectively stimulating or inhibiting estrogen receptors in different tissues, offering...

Facioscapulohumeral Muscular Dystrophy Market Gearing Up for Outstanding…

Roughly 80% of individuals carrying the FSHD gene mutation experience symptoms, while the remaining 20% are asymptomatic, either showing no signs or only very mild symptoms that may go unnoticed until later in life. For FSHD1, children of an affected parent have a 50% likelihood of inheriting the disorder. In FSHD2, the inheritance risk depends on the genetic background of both parents, typically ranging from 25% to 50%. Roughly80%of individuals carrying the FSHD gene mutation experience...

OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels

OSE Immunotherapeutics Launches Newsletter for Individual ShareholdersNANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs, today launched the inaugural edition of its Newsletter, designed specifically for individual shareholders and investors in France and internationally...

EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call…

Second-Quarter and First-Half 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our Second-Quarter and First-Half 2025 Results Conference Call on: Monday, July 28, 2025, at 6:30 pm CEST Dial-in telephone access:If you wish to dial into the...

Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031…

The report analyzes market trends, key players, and future opportunities in-depth. The patient-derived xenograft model market comprises a vast array of products and services expected to register strength in the coming years. The report analyzes market trends, key players, and future opportunities in-depth. The patient-derived xenograft model market comprises a vast array of products and services expected to register strength in the coming years. To explore the valuable insights in the...

ECG Sensor Patches Market worth $2.32 billion by 2032 with 12.0% CAGR |…

Browse in-depth TOC on "ECG Sensor Patches Market" Browse in-depth TOC on "ECG Sensor Patches Market" 270 - Tables 57 - Figures270 - Pages By lead type,the single-lead ECG Sensor Patch segment accounted for the largest market share in 2024 due to its high clinical utility in ambulatory cardiac rhythm tracking, particularly for arrhythmia and post-operative monitoring. These patches are favored in outpatient and home settings because they are lightweight, unobtrusive, and...

Pharmaceutical Packaging Equipment Market worth $14.3 billion by 2030 with 6.3%…

Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market" Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market" 361 - Tables 57 - Figures 404 - Pages By product,Primary packaging equipment plays a crucial role in the pharmaceutical industry, holding the largest market share due to its direct impact on safeguarding the integrity, sterility, and efficacy of various drug formulations. This equipment is essential for an array of dosage forms, including...

UroMems Receives Clearance from the FDA and the French ANSM for Initiating…

This prospective, multicenter trial, called the SOPHIA2 study, will evaluate the safety and efficacy of the UroActive System, the first smart automated artificial urinary sphincter (AUS) for the treatment of SUI. The FDA IDE approval and ANSM clearance follow strong feasibility study results for both women and men in France. This prospective, multicenter trial, called the SOPHIA2 study, will evaluate the safety and efficacy of the UroActive System, the first smart automated artificial urinary...

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate…

LONDON and NEW YORK, July17, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announced it has received $1.9 million in non-dilutive funding to support its ongoing research and development programs. The funding will specifically...

Nearly 75% of Physicians Say Time-Consuming Clinical Trial Searches Delay…

Clinical trials play a vital role in advancing new treatments for patients. However, with over 500,000 clinical trials registered globally and more than 8,000 drugs currently in development, the process of identifying and enrolling patients in relevant trials has become increasingly challenging for physicians. The process is often manual, making it time-consuming and fragmented. This places added strain on physicians and limits visibility to potentially relevant trials. Not only does this slow…

BioNTech Announces Ryan Richardson to Step Down from the Management Board

MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE)–BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the Management Board of BioNTech on September 30, 2025, and as a Board Director at affiliated companies of the BioNTech Group by mutual agreement to pursue new professional opportunities. The process of transitioning his responsibilities to other members of the Management Board is underway, ensuring a...

Embla Medical hf: Embla Medical signs agreement to invest in a majority share in…

REYKJAVIK, Iceland and COPENHAGEN, Denmark, July 17, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today signed an agreement to invest in a majority share (51% of the shares) in privately owned Streifeneder ortho.production GmbH ("Streifeneder"). Today Streifeneder ortho.production is part of Streifeneder KG (Group), a supplier of orthopaedic solutions and operator of a large O&P clinic network in Bayern…

KFSHRC Performs World’s First Robotic-Assisted BiVAD Implantation

A minimally invasive robotic surgery offers a life-saving option for high-risk patients who cannot undergo transplants or traditional open-heart procedures The procedure represents a major advancement in the treatment of bilateral heart failure, which was traditionally performed through full sternotomy, an approach associated with higher surgical risks and prolonged recovery. However, the cardiac surgery team at KFSHRC, led by Prof. Feras Khaliel, successfully performed the operation...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for…

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR…

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR |…

Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR…

Healthcare Dispensing Systems Market worth $6.27 billion by 2030 with 6.3% CAGR…

Orion Group Half-Year Financial Report January–June 2025

EQT to acquire Adalvo, a leading B2B dossier developer

Orion Corporation’s financial reporting and Annual General Meeting in 2026

Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief…

The World Federation of Neurology to Host Global Webinar Uniting UN-ECOSOC, WHO…

Press Release: Sanofi completes acquisition of Blueprint Medicines

SERM Market Shows Promising Growth Trajectory During the Study Period…

Facioscapulohumeral Muscular Dystrophy Market Gearing Up for Outstanding…

OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels

EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call…

Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031…

ECG Sensor Patches Market worth $2.32 billion by 2032 with 12.0% CAGR |…

Pharmaceutical Packaging Equipment Market worth $14.3 billion by 2030 with 6.3%…

UroMems Receives Clearance from the FDA and the French ANSM for Initiating…

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate…

Nearly 75% of Physicians Say Time-Consuming Clinical Trial Searches Delay…

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Embla Medical hf: Embla Medical signs agreement to invest in a majority share in…

KFSHRC Performs World’s First Robotic-Assisted BiVAD Implantation